» Articles » PMID: 26831062

Cardia and Non-Cardia Gastric Cancer Have Similar Stage-for-Stage Prognoses After R0 Resection: a Large-Scale, Multicenter Study in China

Overview
Specialty Gastroenterology
Date 2016 Feb 3
PMID 26831062
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Although the clinicopathological features of cardia gastric cancer (GC) differ from those of non-cardia GC, it is unclear whether the former has poorer prognosis than the latter. The aim of this study was to compare clinicopathological characteristics and prognosis between cardia and non-cardia GC. From December 2009 to December 2011, 1633 patients who had undergone R0 resection of GC at four Chinese centers were enrolled in this study. Their clinicopathological features and survival outcomes were evaluated. Compared with non-cardia GC, cardia GC was associated with a significantly higher proportion of male patients, older age, more advanced pathological stage, and less-favorable clinicopathological features at diagnosis. The 5-year survival rate was significantly lower in the cardia GC group than in the non-cardia GC group. However, no significant difference in overall survival (OS) was observed between the two groups at any pathological TNM stage. Pathological stage was confirmed as an independent prognostic factor of OS. More advanced disease represents most of the cases in this Chinese population. Compared with patients with non-cardia GC, patients with cardia GC were diagnosed at a more advanced stage and had worse prognosis after undergoing R0 resection. However, cardia and non-cardia GCs have similar stage-for-stage prognoses.

Citing Articles

Disparities in overall survival of gastric cancer patients after radical gastrectomy: an age and rural-urban residence-based cohort study with propensity score matching analysis.

He F, Xu R, Zhou D, Zhou X, Chen X Sci Rep. 2025; 15(1):8479.

PMID: 40074844 PMC: 11903829. DOI: 10.1038/s41598-025-93463-x.


Developing a prognostic signature: identifying differentially expressed genes in cardia and non-cardia gastric cancer for immunity and therapeutic sensitivity analysis.

Li X, Zhou C, Zhu Y, Wang W, Han S, Zou Y J Gastrointest Oncol. 2024; 15(4):1446-1463.

PMID: 39279940 PMC: 11399880. DOI: 10.21037/jgo-24-541.


Survival of patients with gastric cancer surgically treated at the National Cancer Center of China from 2011 to 2018 according to stage at diagnosis.

Kang W, Zeng H, Xiong J, Li Y, Jin P, Shao X J Natl Cancer Cent. 2024; 2(3):132-138.

PMID: 39036446 PMC: 11256526. DOI: 10.1016/j.jncc.2022.07.002.


Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery.

Ren X, Huang T, Tang X, Ma Q, Zheng Y, Hu Z Front Oncol. 2023; 13:1223857.

PMID: 37655111 PMC: 10466399. DOI: 10.3389/fonc.2023.1223857.


A predictive model for early death in elderly patients with gastric cancer: A population-based study.

Yang W, Fang Y, Niu Y, Sun Y Front Oncol. 2022; 12:972639.

PMID: 36072801 PMC: 9444320. DOI: 10.3389/fonc.2022.972639.


References
1.
Ohno S, Tomisaki S, Oiwa H, Sakaguchi Y, Ichiyoshi Y, Maehara Y . Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg. 1995; 180(5):577-82. View

2.
Dassen A, Lemmens V, van de Poll-Franse L, Creemers G, Brenninkmeijer S, Lips D . Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer. 2010; 46(6):1101-10. DOI: 10.1016/j.ejca.2010.02.013. View

3.
An J, Baik Y, Choi M, Noh J, Sohn T, Bae J . The prognosis of gastric cardia cancer after R0 resection. Am J Surg. 2009; 199(6):725-9. DOI: 10.1016/j.amjsurg.2009.04.012. View

4.
Steevens J, Botterweck A, Dirx M, van den Brandt P, Schouten L . Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol. 2009; 22(6):669-78. DOI: 10.1097/MEG.0b013e32832ca091. View

5.
Piso P, Werner U, Lang H, Mirena P, Klempnauer J . Proximal versus distal gastric carcinoma--what are the differences?. Ann Surg Oncol. 2000; 7(7):520-5. DOI: 10.1007/s10434-000-0520-0. View